Abstract | PURPOSE: METHODS: Forty-five vitreous samples were collected from 32 patients (32 eyes) undergoing vitrectomy for diabetic retinopathy (DM group) and from 13 patients (13 eyes) (control group) who were age- and sex-matched patients with idiopathic macular hole or epiretinal membrane with no systemic conditions. The levels of the cross-links were determined using high-performance liquid chromatography after acid hydrolysis and pretreatment with SP- Sephadex. RESULTS: The levels of pentosidine, pyridinoline, and deoxypyridinoline were 27.3 +/- 23.1 (mean +/- SD) pmol/mL (detectable in 45 of 45 specimens), 79.0 +/- 40.2 ng/mL (43 of 45 specimens), and 54.0 +/- 9.5 (32 of 45 specimens) ng/mL, respectively. When the vitreous samples from the DM and the control groups were compared, a significant difference (P <.05) was found in the pentosidine level but not in the levels of pyridinoline or deoxypyridinoline. No significant correlations were found between age and the cross-links. Significant correlations (P <.01) were found among the cross-links. CONCLUSIONS: The results indicate that mature cross-link substances exist in the human vitreous. The results also suggest that glycation may occur in the vitreous after mature cross-links form and result in the formation of AGE cross-links. In human vitreous from patients with DM, increased levels of AGE cross-links may stabilize the formation of mature cross-links, but they did not increase the mature cross-links.
|
Authors | Yukihiro Matsumoto, Masaaki Takahashi, Makoto Chikuda, Kiyomi Arai |
Journal | Japanese journal of ophthalmology
(Jpn J Ophthalmol)
2002 Sep-Oct
Vol. 46
Issue 5
Pg. 510-7
ISSN: 0021-5155 [Print] Japan |
PMID | 12457909
(Publication Type: Journal Article)
|
Chemical References |
- Amino Acids
- Glycation End Products, Advanced
- pyridinoline
- deoxypyridinoline
- Arginine
- pentosidine
- Lysine
|
Topics |
- Adult
- Aged
- Aging
(metabolism)
- Amino Acids
(metabolism)
- Arginine
(analogs & derivatives, metabolism)
- Diabetic Retinopathy
(metabolism)
- Glycation End Products, Advanced
(metabolism)
- Humans
- Lysine
(analogs & derivatives, metabolism)
- Middle Aged
- Reference Values
- Vitreous Body
(metabolism)
|